1. The activities of the oxidative enzymes (glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase) and of the non-oxidative enzymes (transaldolase, transketolase, ribose 5-phosphate isomerase and ribulose 5-phosphate 3-epimerase) of the pentose phosphate pathway were measured at various times during the first 24h of skeletalmuscle regeneration after administration of Marcaine, a myotoxic local anaesthetic. 2. The activities of the oxidative enzymes increased after Marcaine injection and rose to 9 times control activities by 24h. 3. The activities of all non-oxidative enzymes were increased after Marcaine administration, but to a much smaller extent than the oxidative enzymes (1.1-1.7-fold). 4. Histochemical analysis localized glucose 6-phosphate dehydrogenase activity within muscle fibres of control and Marcaine-treated muscles. 5. Cycloheximide or actinomycin D prevented the increase in oxidative enzyme activities, suggesting a requirement for synthesis of protein and RNA.
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The activity of the pentose phosphate pathway in skeletal muscle is enhanced during embryogenesis (Beatty et al., 1966) and in a number of experimental situations, including denervation (Turner & Manchester, 1972; Ilyin et al., 1975; Robbins & Hall, 1976) , ischaemia (Archangeli et al., 1973) and administration of Marcaine (bupivacaine, 1-n-butyl-DL-piperidine-2-carboxylic acid 2,6-dimethylanilide hydrochloride) (Rifenberick et al., 1974; Wagner et al., 1977b) , a myotoxic local anaesthetic that causes acute degeneration of muscle fibres followed by rapid and complete regeneration (Benoit & Belt, 1970) . At 1 day after local application of Marcaine, fibres of the rat extensor digitorum longus muscle undergo degeneration characterized morphologically by disappearance of the plasma membrane, alteration of mitochondria and the sarcotubular system, dissolution of myofibrils, and degeneration of myonuclei (Jirmanova & Thesleff, 1972) . At 2 days after application of Marcaine early signs of regeneration, notably the presence of presumptive myoblasts, are discernible (Jirmanova & Thesleff, 1972) . If Marcaine is injected intramuscularly in combination with hyaluronidase, widespread muscle damage is observed and muscle fibres appear to undergo regeneration in a synchronous manner (Hall-Craggs, 1974) . In an effort to identify early biochemical responses to the regenerative stimulus, i.e. those changes that might be involved in the initiation of regeneration, we injected Marcaine and hyaluronidase intramuscularly and assayed the enzymes of the pentose phosphate pathway during the first 24h of skeletal-muscle regeneration.
Since regeneration is accompanied by an inflammatory response (Hall-Craggs, 1974 ) involving small Vol. 170 phagocytic cells that contain high activities of acid hydrolases (Steinman & Cohn, 1974) , we also measured the activity of,-glucuronidase, a typical lysosomal acid hydrolase, to assess the contribution of the inflammatory response to changes in enzyme activities in Marcaine-treated muscles.
The data below demonstrate dramatic early enhancement of the rate-limiting enzymes of the pentose phosphate pathway, mediated via a process that is blocked by inhibitors ofRNA and protein synthesis. Some of these results have been presented in preliminary form (Wagner et al., 1977a,c (Hall-Craggs, 1974) to evaluate initial responses to the myotoxic drug. This procedure is a modification of the three-dailyinjection regimen of Hall-Craggs (1974) . The present regimen of Marcaine plus hyaluronidase causes a massive degenerative response, although not all fibres are involved, as appears to be the case after three daily Marcaine injections (Hall-Craggs, 1974; Hall-Craggs & Singh Seyan, 1975) .
The contralateral anterior tibial muscle was not injected, and served as the control. In early experiments, injection of control muscles with 0.9 % NaCl produced a small increase in glucose 6-phosphate dehydrogenase activity. At This was assayed by a modification of the method of Glock & McLean (1953) . The medium for the assay contained 50mM-Tris/HCl, pH8.1, 3.0mM-glucose 6-phosphate, 0.5mM-NADP+ and 0.1 unit (1 pmol/ min) of 6-phosphogluconate dehydrogenase, in a total volume of 1.Oml.
6-Phosphogluconate dehydrogenase (EC 1.1.1.44). This was assayed in a medium containing 50mM-Tris/HCl, pH8.1, 3.OmM-6-phosphogluconate and 0.1 mM-NADP+ in a final volume of 1.Oml.
Absorbance changes were also assessed in the absence of substrate and this blank rate was subtracted from the rate with substrate. Inclusion of Marcaine in assay cuvettes at 0.77 or 1.54mm (estimated Marcaine concentration in injected muscles) had no effect on glucose 6-phosphate dehydrogenase or 6-phosphogluconate dehydrogenase activities. The non-oxidative enzymes were assayed by modifications of the coupled assay systems described by Novello & McLean (1968) . Incubation medium for each enzyme comprised 50mM-Tris/HCl, pH 7.5, 0.2imM-NADH, 2 units of a-glycerophosphate dehydrogenase and 14.4 units of triose phosphate isomerase, with the additions described below, in a final volume of 1.0ml.
Transaldolase (EC 2.2.1.2). This was assayed by adding 20mM-fructose 6-phosphate and 1.0mM-erythrose 4-phosphate to the reaction medium.
Transketolase (EC 2.2.1.1). This was assayed by adding 1.0 unit of D-ribulose 5-phosphate 3-epimerase, 1.0 unit of ribose 5-phosphate isomerase and 5mM-ribose 5-phosphate to the reaction medium.
Ribose 5-phosphate isomerase (EC 5.3.1.6). This was assayed by adding 5 mM-ribose 5-phosphate, 0.25 unit of transketolase and 0.25 unit of D-ribulose 5-phosphate 3-epimerase to the reaction medium.
D-Ribulose 5-phosphate 3-epimerase (EC 5.1.3.1). This was assayed by adding 5 mM-ribose 5-phosphate, 0.1 unit of transketolase, and 0.1 unit of ribose 5-phosphate isomerase to the reaction medium.
f9-Glucuronidase (EC 3.2.1.31). This was assayed with 4-methylumbelliferyl ,B-D-glucuronide as substrate in 0.1 M-sodium acetate buffer (pH 3.75) in the presence of 0.2% (v/v) Triton X-100. The assay was carried out as described by Max et al. (1971) .
Enzymes were assayed by monitoring the change in A340 in a Beckman model 25 recording spectrophotometer at 250C. Rates were linear with respect to time (up to 5min) and protein concentrations. Substrate concentrations were saturating. Addition of Mg2+ had no effect on enzyme activities. Transketolase activity was not influenced by the addition of thiamin pyrophosphate to the incubation medium; presumably sufficient amounts of Mg2+ and thiamin are present in supernatants. Enzyme specific activities were calculated as nmol/min per mg of supernatant protein and the data are presented as means ±S.E.M. Specific activities of the oxidative and nonoxidative enzymes agree with published values (Tan & Wood, 1969; Turner & Manchester, 1972; Kauffman et al., 1976; Heinrich et al., 1976) .
Protein determinations
Supernatant fractions were analysed for protein by the method of Lowry et al. (1951) , with crystalline bovine serum albumin as standard. Non-collagen protein was determined by diluting homogenates with 9 vol. of0.1 M-NaOH (Lilienthal et al., 1949) and leaving the resulting mixture overnight at 25°C. After centrifugation at 800g, non-collagen protein was determined in the resulting supernatants by the method of Lowry et al. (1951) . 1978 g8 Histochemical and histological procedures Control and Marcaine-treated muscles were mounted on cryostat chucks and quenched in a Dewar flask containing acetone cooled by solid CO2. Sections (10pm) were cut at -15°C, air-dried and stained for glucose 6-phosphate dehydrogenase or Nissl substance as described previously (Kauffman et al., 1974) .
Statistical analysis
The activities of the non-oxidative enzymes of the pentose phosphate pathway were compared by twofactor analysis of variance with repeated measures on one factor (Winer, 1962) .
Results and Discussion
The activities of glucose 6-phosphate dehydrogenase ( Fig. 1 ) and 6-phosphogluconate dehydrogenase (Fig. 2) (Narayanan & Eapen, 1973) .
Further, Grampp et al. (1972) reported a 50-60% decrease in uridine incorporation into acid-precipitable material by actinomycin D at a dose of0.5 mg/kg. Thus protein and RNA synthesis seems to be required for elevation of the activities of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. Although administration of cycloheximide at the time of Marcaine injection prevented the increase of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase, cycloheximide injection at 2 or 4h after Marcaine did not (results not shown). This result suggests that activation of protein synthesis occurred shortly after treatment with Marcaine, after which time enzyme activities continued to increase even in the presence of the inhibitor.
To determine whether the presence of a stimulatory factor or absence of an inhibitory factor caused enhanced glucose 6-phosphate dehydrogenase activity in regenerating muscles, supernatants of Marcainetreated and control muscles were mixed and the mixture was assayed for glucose 6-phosphate dehydrogenase. The activities of the mixed supernatants were additive at 2, 6 and 24h after Marcaine (results not shown). Therefore no stimulatory substance is present. Similarly, normal muscles do not appear to contain inhibitory substances that would have to be destroyed before an increase of glucose 6-phosphate dehydrogenase activity could occur. We conclude that glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase are rapidly induced in skeletal muscle in response to Marcaine. Time after Marcaine injection (h) Fig. 1 . Glucose 6-phosphate dehydrogenase activity of Afarcaine-treated (0) and control (A) rat anterior tibial muscles At indicated times after intramuscular injection of Marcaine, rat anterior tibial muscles were excised, homogenized and centrifuged. The supernatant fractions were assayed for glucose 6-phosphate dehydro- Time after Marcaine injection (h) Fig. 2 . 6-Phosphogluconate dehydrogenase activity of Marcaine-treated (-) and control (A) rat anterior tibial muscles At indicated times after intramuscular injection of Marcaine, rat anterior tibial muscles were excised, homogenized and centrifuged. The supernatant fractions were assayed for 6-phosphogluconate dehydrogenase activity as described in the text. Values shown are means of four determinations+s.E.M. A possible complication of these results resides in the phagocytic-cell infiltration, which is a prominent feature in the early phases of muscle regeneration (Hall-Craggs, 1974) . It is unlikely, however, that phagocytic-cell infiltration contributed significantly to the increase in glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase during the first 8 h after Marcaine injection. Histochemical studies performed at 8 h localized glucose 6-phosphate dehydrogenase almost exclusively within muscle fibres (Plate lb), and not within interstitial cells.
Although infiltration of muscle by phagocytic cells was just discernable at 8 h, by 24h Nissl staining revealed infiltration of the muscle by large numbers of phagocytic cells (Plate Ic). Phagocytic cells probably contributed to the increase of glucose 6-phosphate dehydrogenase activity observed at this time, since localization of the glucose 6-phosphate dehydrogenase indicated that enzyme activity was present in these cells as well as muscle fibres (Plates 1 b, 1 c) . Cycloheximide, which prevented the increase in glucose 6-phosphate dehydrogenase 7h after Marcaine, did not alter invasion of muscle by phagocytic cells, which still stained histochemically for the enzyme (results not shown).
Comparison of the time course of glucose 6-phosphate dehydrogenase with that of f-glucuronidase, which might be enriched in phagocytic cells, showed that the activities did not increase in parallel (Fig. 3 ).
There was no substantial increase in I8-glucuronidase until 6-8 h after Marcaine injection, whereas glucose 6-phosphate dehydrogenase activity increased about 3-fold during this period (Fig. 3) . By using histological techniques similar to those in the present study, Smith (1965) and Snow (1973) also showed that glucose 6-phosphate dehydrogenase was localized within muscle cells in regenerating muscle. Thus it appears that enhanced enzyme activity resides in muscle fibres themselves for at least the first 6-8h Time after Marcaine injection (h) Fig. 3 . Glucose 6-phosphate dehydrogenase and /3-glucuronidase in Marcaine-treated and control rat anterior tibial muscles At indicated times after Marcaine injection, muscles were excised, homogenized and centrifuged. The supernatant fractions were assayed for glucose 6-phosphate dehydrogenase (e) and the homogenate was assayed for ,8-glucuronidase (0). Enzyme activity was expressed as nmol/min per mg of supernatant protein (glucose 6-phosphate dehydrogenase) or nmol/min per mg of non-collagen protein (,/-glucuronidase).
after Marcaine, after which time phagocytic cells contribute to the increase in enzyme activities. Figs.  1 and 2 show that the secondary increase in the activities of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase from 15-24h corresponded closely to the increase in IJ-glucuronidase activity in muscles injected with Marcaine.
Glucose 6-phosphate dehydrogenase in liver has a half-life of about 15h (Freedland, 1968; Goldberg & St. John, 1976) . Although the half-life of glucose 6-phosphate dehydrogenase in regenerating muscle has yet to be determined, the rapid increase in activity 1978 (Goldberg & St. John, 1976) . Thus the rapid induction of glucose 6-phosphate dehydrogenase observed in the present study may represent adaptation to the regenerating state in skeletal muscle.
It should be noted that regulation of glucose 6-phosphate dehydrogenase is complex and the process differs among experimental systems. For example, enhancement of glucose 6-phosphate dehydrogenase activity in liver (Rudack et al., 1971; Garcia & Holten, 1975) , uterus (Smith & Barker, 1974) and hepatoma (Selmeci & Weber, 1976) , and 6-phosphogluconate dehydrogenase activity in liver (Procsal et al., 1976) and mammary gland (Betts & Mayer, 1977) , occur via newly synthesized enzyme protein.
On the other hand, increased glucose 6-phosphate dehydrogenase activity may be accomplished without synthesis of enzyme protein, although the increase is blocked by actinomycin D or cycloheximide (Yagil et al., 1974; Hizi & Yagil, 1974) . In these situations, enhanced activity apparently results from modification of pre-existing enzyme molecules (Hizi & Yagil, 1974) . Post-transcriptional regulation of glucose 6-phosphate dehydrogenase synthesis has been postulated to occur in liver after carbon tetrachloride injury (Watanabe & Taketa, 1973) , and in erythrocytes and leukaemic granulocytic cells (Kahn et al., 1976) .
The non-oxidative enzymes (Table 1) ofthe pentose phosphate pathway were not affected to the same extent as were glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. Transketolase, transaldolase, ribose 5-phosphate isomerase and ribulose 5-phosphate 3-epimerase activities were slightly elevated (1.5? 1.5, 1.3 and 1.1 times Vol. 17Q control respectively) 2h after injection of Marcaine. The activities of these enzymes remained elevated at 6h (1.5, 1.5, 1.7 and 1.4 times control respectively). By 24h, transaldolase, ribose 5-phosphate isomerase and ribulose 5-phosphate 3-epimerase were significantly elevated (1.2, 1.4 and 1.2 times control respectively). It is possible that the small increase in the activities of the non-oxidative enzymes is due to the inflammatory cell response. The activities of the non-oxidative enzymes in normal adult muscles are at least 10 times those of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase (Figs. 1 and 2, Table 2 ).
Thus elevation of the activities of the oxidative enzymes may represent the major factor contributing to increased flux through the pentose pathway during the initial stages of muscle regeneration. Enhanced activities of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase have been associated with elevated activity of the pentose phosphate pathway ( Figs. 1 and 2 ; cf. Beaconsfield & Carpi, 1964; Rifenberick et al., 1974; Wagner et al., 1977a) and probably reflect accelerated glucose utilization for the production of nucleic acids (Beaconsfield & Reading, 1964) and lipids. In this regard, increased quantities of RNA have been noted in a number of studies on muscle regeneration (Gallucci et al., 1966; Susheela et al., 1968; Carlson, 1970; Neerunjun & Dubowitz, 1974 
